These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22970983)

  • 1. Prevalence and genotypic relatedness of carbapenem resistance among multidrug-resistant P. aeruginosa in tertiary hospitals across Thailand.
    Khuntayaporn P; Montakantikul P; Mootsikapun P; Thamlikitkul V; Chomnawang MT
    Ann Clin Microbiol Antimicrob; 2012 Sep; 11():25. PubMed ID: 22970983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of carbapenemase genes among multidrug-resistant
    Saengsuwan P; Kositpantawong N; Kawila S; Patugkaro W; Romyasamit C
    Saudi Med J; 2022 Sep; 43(9):991-999. PubMed ID: 36104060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular investigation of carbapenem resistance among multidrug-resistant Pseudomonas aeruginosa isolated clinically in Thailand.
    Khuntayaporn P; Montakantikul P; Santanirand P; Kiratisin P; Chomnawang MT
    Microbiol Immunol; 2013 Mar; 57(3):170-8. PubMed ID: 23278679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa.
    Tam VH; Chang KT; Abdelraouf K; Brioso CG; Ameka M; McCaskey LA; Weston JS; Caeiro JP; Garey KW
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1160-4. PubMed ID: 20086165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Carbapenem Resistance in Multidrug-Resistant Clinical Isolates of Pseudomonas aeruginosa from a Croatian Hospital.
    Bubonja-Sonje M; Matovina M; Skrobonja I; Bedenic B; Abram M
    Microb Drug Resist; 2015 Jun; 21(3):261-9. PubMed ID: 25565041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan.
    Sekiguchi J; Asagi T; Miyoshi-Akiyama T; Kasai A; Mizuguchi Y; Araake M; Fujino T; Kikuchi H; Sasaki S; Watari H; Kojima T; Miki H; Kanemitsu K; Kunishima H; Kikuchi Y; Kaku M; Yoshikura H; Kuratsuji T; Kirikae T
    J Clin Microbiol; 2007 Mar; 45(3):979-89. PubMed ID: 17122009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa.
    Hu Y; Qing Y; Chen J; Liu C; Lu J; Wang Q; Zhen S; Zhou H; Huang L; Zhang R
    Microbiol Spectr; 2021 Dec; 9(3):e0134421. PubMed ID: 34817230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals.
    García-Castillo M; Del Campo R; Morosini MI; Riera E; Cabot G; Willems R; van Mansfeld R; Oliver A; Cantón R
    J Clin Microbiol; 2011 Aug; 49(8):2905-10. PubMed ID: 21697331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999-2003).
    Jones RN; Deshpande L; Fritsche TR; Sader HS
    Diagn Microbiol Infect Dis; 2004 Jul; 49(3):211-6. PubMed ID: 15246512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
    Gutiérrez O; Juan C; Cercenado E; Navarro F; Bouza E; Coll P; Pérez JL; Oliver A
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4329-35. PubMed ID: 17938181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology of Pseudomonas aeruginosa isolated from infected ICU patients: a French multicenter 2012-2013 study.
    Slekovec C; Robert J; van der Mee-Marquet N; Berthelot P; Rogues AM; Derouin V; Cholley P; Thouverez M; Hocquet D; Bertrand X
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):921-926. PubMed ID: 30826996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals.
    Wang J; Zhou JY; Qu TT; Shen P; Wei ZQ; Yu YS; Li LJ
    Int J Antimicrob Agents; 2010 May; 35(5):486-91. PubMed ID: 20185276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nosocomial spread of class 1 integron-carrying extensively drug-resistant Pseudomonas aeruginosa isolates in a Thai hospital.
    Kiddee A; Henghiranyawong K; Yimsabai J; Tiloklurs M; Niumsup PR
    Int J Antimicrob Agents; 2013 Oct; 42(4):301-6. PubMed ID: 23845503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of multidrug-resistant Pseudomonas aeruginosa in a French university hospital.
    Cholley P; Gbaguidi-Haore H; Bertrand X; Thouverez M; Plésiat P; Hocquet D; Talon D
    J Hosp Infect; 2010 Dec; 76(4):316-9. PubMed ID: 20692070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.
    McCracken M; Mataseje LF; Loo V; Walkty A; Adam HJ; Hoban DJ; Zhanel GG; Mulvey MR;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):335-41. PubMed ID: 21353962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients.
    Adachi JA; Perego C; Graviss L; Dvorak T; Hachem R; Chemaly RF; Raad II
    Am J Infect Control; 2009 Aug; 37(6):442-6. PubMed ID: 19118923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
    Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic diversity among multidrug resistant Pseudomonas aeruginosa and Acinetobacter species at Mulago Hospital in Kampala, Uganda.
    Kateete DP; Nakanjako R; Okee M; Joloba ML; Najjuka CF
    BMC Res Notes; 2017 Jul; 10(1):284. PubMed ID: 28705201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-16 study.
    McCracken MG; Adam HJ; Blondeau JM; Walkty AJ; Karlowsky JA; Hoban DJ; Zhanel GG; Mulvey MR;
    J Antimicrob Chemother; 2019 Aug; 74(Suppl 4):iv32-iv38. PubMed ID: 31505643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of P. aeruginosa harboring bla CTX-M-2, bla GES-1 and bla GES-5, bla IMP-1 and bla SPM-1 causing infections in Brazilian tertiary-care hospital.
    Polotto M; Casella T; de Lucca Oliveira MG; Rúbio FG; Nogueira ML; de Almeida MT; Nogueira MC
    BMC Infect Dis; 2012 Aug; 12():176. PubMed ID: 22863113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.